13:51:02 Europe / Stockholm

Kalender

2024-08-30 Kvartalsrapport 2024-Q2
2024-04-11 Ordinarie utdelning MONSO 0.00 DKK
2024-04-10 Årsstämma 2024
2024-03-06 Bokslutskommuniké 2023
2023-09-07 Kvartalsrapport 2023-Q2
2023-04-13 Ordinarie utdelning MONSO 0.00 DKK
2023-04-12 Årsstämma 2023
2023-03-08 Bokslutskommuniké 2022
2022-12-20 Extra Bolagsstämma 2022
2022-08-31 Kvartalsrapport 2022-Q2
2022-04-07 Ordinarie utdelning MONSO 0.00 DKK
2022-04-06 Årsstämma 2022
2022-03-09 Bokslutskommuniké 2021
2021-11-16 Extra Bolagsstämma 2021
2021-08-26 Kvartalsrapport 2021-Q2
2021-04-15 Ordinarie utdelning MONSO 0.00 DKK
2021-04-14 Årsstämma 2021
2021-03-10 Bokslutskommuniké 2020

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorInformationsteknik
IndustriProgramvara
Monsenso är verksamt inom IT-sektorn. Bolaget är specialiserat inom tillhandahållandet av digitala uppföljningssystem för vård och omsorg, samt sjukhus. Lösningarna är mjukvarubaserade och används huvudsakligen för uppföljning av patienters hälsotillstånd, samt för intern bevakning och analys. Störst verksamhet återfinns inom den nordiska marknaden. Huvudkontoret ligger i Köpenhamn.
2021-03-23 20:30:59

23.3.2021 20:30:58 CET | Monsenso | Chang. board/management/certified advisors

Notice to attend the general meeting will be issued separately.

Company announcement no. 5-2021

Copenhagen, 2021.03.23

Monsenso - a leading provider of digital health solutions for mental health - plans to further strengthen the board by nominating a new professional board member with strong qualifications and competencies to support the company’s growth journey: Maria Helene Hjorth, CEO at VP Securities A/S.

Maria Hjorth will replace Jukka Pertola, who – as previously announced – will withdraw from the board of directors in order to comply with good board governance practices by reducing his number of board positions. 

The board and the management of Monsenso would like to thank Jukka Pertola for his efforts in supporting the management, the company in general and particularly the listing on Nasdaq First North in 2020. 

The new board plans to constitute itself with Maria Hjorth as the Chairman and Jakob Bardram as the Vice Chairman following the ordinary Annual General Meeting on April 14, 2021, where Jukka Pertola is expected to resign as the Chairman. 

The nomination of Maria Hjorth follows a change in the board in January, where Peter Høngaard Andensen and Jacob Hahn Michelsen were elected with the aim to strengthen the competences and diversity of the board.

Jukka Pertola commented:” It is sad to pass on the chairmanship, but I have to do so to comply with demands related to good corporate governance. On the other hand, I am very pleased that with Maria Hjorth and the changes made in January, we have a competent and experienced board that is well positioned to help Monsenso reach the next level. Jacob Hahn Michelsen and Peter Høngaard Andersen brought extensive experience in pharma- and health-related software, medical applications, science and research, pharmaceuticals, neurology, innovation and funding. Maria Hjorth’s experiences from top management, financial businesses, investor relations and M&A is a great supplement to the rest of the board”.

Any inquiries regarding this notice should be directed to:

Monsenso:

Chairman of the board
Jukka P. Pertola
Tel. +45 20 19 82 20
E-mail: jukka.pertola@pertola.com


CEO
Thomas Lethenborg
Tel. +45 21 29 88 27
E-mail: lethenborg@monsenso.com 

Certified Adviser:

Norden CEF ApS
John Norden
Tel. +45 20 72 02 00
E-mail: jn@nordencef.dk

About Monsenso

Monsenso is an innovative technology company offering a digital health solution. Our mission is to help provide better mental health to more people at lower costs.  Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit  www.monsenso.com

Attachments